View Post

December 15, 2020

COVID-19 Crisis: Why Now is the Time to Invest in Glycemic Management

In by Andrea Martucci

COVID-19 Crisis: Why Now is the Time to Invest in Glycemic Management Outcomes for patients with COVID-19 and hyperglycemia: increased mortality, longer length of stay (LOS) In the midst of the worldwide novel coronavirus pandemic, emerging data suggests that glycemic control for patients with and without a previous diagnosis of diabetes is a critical component for managing the care of …

View Post

April 10, 2020

Insulin Management and COVID-19 Resources

In by Susan Lawrence

Insulin Management and COVID-19 Resources What We Know About Patients with Diabetes or Hyperglycemia and COVID-19 Why Glycemic Control is Important: It has been widely studied that the incidence of diabetes predisposes patients to an increased risk of infections1 and an increased risk of complications during infection2. Additionally, the occurrence of hyperglycemia contributes to an impaired immune response.3 Emerging Studies …

View Post

October 1, 2017

Clinicians and Patients Speak to the Efficacy, Safety and Value of Glytec’s eGlycemic Management System.

In by Heather DelCarpini

Clinicians and Patients Speak to the Efficacy, Safety and Value of Glytec’s eGlycemic Management System.

View Post

June 1, 2017

Clinical and financial impact of inpatient diabetes care and glycemic management in the ICU and Non-ICU. Dr. Guillermo Umpierrez of Emory University and Grady Health.

In by Susan Lawrence

Clinical and financial impact of inpatient diabetes care and glycemic management in the ICU and Non-ICU. Dr. Guillermo Umpierrez of Emory University and Grady Health. TOPIC TIME STAMP Introducing Dr. Guiellermo Umpierrez 00:00 Diabetes Research at Emory University 01:18 Hypoglycemia in the ICU 03:24 Clinical Inertia Surrounding Glycemic Control 05:14 Current Glycemic Guidelines and Targets 06:06 Reducing Complications for Cardiovascular …

View Post

September 1, 2016

Clinical and financial outcomes of intensive glucose control for cardiac surgery patients, including results of the GLUCO-CABG Trial. Dr. Guillermo Umpierrez of Emory University and Grady Health.

In by Heather DelCarpini

Clinical and financial outcomes of intensive glucose control for cardiac surgery patients, including results of the GLUCO-CABG Trial. Dr. Guillermo Umpierrez of Emory University and Grady Health.